The latest at MBC Biolabs
The latest at MBC Biolabs
Amgen Incubators Grow Startup for Harvest
Venture division seeks access to technology, potential takeovers. San Fernando Valley Business Jo [...]
Kite Pharma and Cell Design Labs Announce Exclusive Research Collaboration
Using Molecular ‘On/Off Switches’ for CAR T-Cell Immunotherapies Kite to License Cell Design Labs [...]
Cell Design Labs Executes Series of Private Financings
New Company Focused on Discovering and Developing Next-Generation Immunotherapies for Cancer and [...]
Avant Completes Acquisitions of Amarantus and Theranostics Health
Avant Diagnostics announced today that it has completed its previously announced acquisitions of [...]
ViewPoint Therapeutics Raises $4 Million in Series A Financing
ViewPoint Therapeutics, Inc., a privately-held biotechnology company pioneering the development o [...]
Miroculus Acquires Microfluidics Firm Kapplex
Miroculus, a San Francisco startup developing microRNA-based diagnostic tests, said Monday that i [...]
Perlstein Lab continues their rare disease drug discovery
Perlstein Lab, or PLab as it is also known, continues to hone its automated drug discovery platfo [...]
Startup Miroculus Shares Vision for Rapid, Inexpensive miRNA Diagnostics at Tri-Con
Molecular diagnostics startup Miroculus is going all in on microRNAs as the ideal blood-based bio [...]
IBM Watson adds Tiatros patient-centered social network to system
San Francisco start-up Tiatros, a doctor-driven, patient-centered social network, has joined the [...]
Immucor and Sirona Genomics receive the CE mark for Mia Fora NGS system for HLA typing
Immucor and Sirona Genomics announced this week that they have received the CE mark for their Mia [...]
Laboratory Space Shortage Constrains Southside San Francisco Biotech Growth
QB3@953, a biotech incubator, has been so successful that many of the startups housed there are s [...]
Pfizer invests in 4D Molecular Therapeutics, a maker of gene delivery vectors
Pfizer ($PFE) announced earlier this month that it is financing the drug discovery efforts of fou [...]
Amarantus Inks Deal to Merge Dx Unit with Avant Diagnostics
NEW YORK (GenomeWeb) – Amarantus Bioscience Holdings announced today that it has signed a letter [...]
Dementia Discovery Fund Chooses Alector for First Investment
LONDON—A promising new avenue in Alzheimer’s research that focuses on the eradication of brain p [...]
Alector Announces $29.5M Series D Financing
Alector LLC, a biotech company pioneering the discovery and development of first-in-class, immun [...]
4D Molecular Therapeutics Announces Collaboration With Pfizer, Inc.
for Cardiac Gene Therapy Vector Discovery and Development 4D Molecular Therapeutics (4DMT), a le [...]
Fay Christodoulou, CSO, Miroculus
The notion of small molecules that detect dozens of cancers may sound like something out of a sci [...]
David Whitlock of AOBiome | Q&A
Chemical engineer David Whitlock has made a splash in the media as of late, due to his lack of “ [...]
How Bell Biosystems is using naturally magnetic bacteria to track cell therapies
With FDA calling for non-invasive new tracking systems to accompany cell therapies, Bell Biosyste [...]
Amarantus Announces Issuance of Australian Patent
Covering Eltoprazine Treatment of Parkinson’s Disease and Alzheimer’s Disease Amarantus Bioscien [...]
Blueprint Genetics Plans to Boost Inherited Disease Panel Portfolio Next Year
Finnish hereditary disease diagnostics firm Blueprint Genetics plans to significantly expand its [...]
Symic Biomedical Selects Osteoarthritis Clinical Candidate
Symic Biomedical, a clinical-stage biotherapeutics company developing multiple compounds that tar [...]
A guy who hasn’t showered in 12 years just helped launch a skin care company
Forgoing a shower, even for a day, makes some people want to hide from society and double up on t [...]
A new dawn for cataracts
On Thursday, November 6, scientists from ViewPoint Therapeutics published an article titled "Phar [...]